A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
- Status
- TERMINATED
- Phase
- PHASE1
Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC
- Status
- TERMINATED
- Phase
- PHASE2
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate CCS1477 in Advanced Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2